![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Maxim Receives $1 Million Development Milestone Payment
Maxim Receives $1 Million Development Milestone Payment
Maxim Pharmaceuticals, Inc.
reported that it achieved a $1 million development milestone under an agreement
with Myriad Genetics. The milestone is based on the dosing of the first patient
in a Phase I clinical program designed to evaluate the safety and pharmacokinetic
profile of MPC-6827 in patients with advanced solid tumors.
Big
News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct